Mexico watchdog finds Big Pharma faces no competition on some drugs

08/09/2017 Reuters

pharmaceuticalMEXICO CITY (Reuters) – Pharmaceutical companies including GlaxoSmithKline, Pfizer and Sanofi-Aventis face no competition for certain drugs in Mexico from generics that are readily available elsewhere, a senior Mexican antitrust official said on Wednesday.

The companies have done nothing illegal, Juan Manuel Espino, Cofece’s director of economic studies, said at a presentation of the body’s probe into the Mexican drugs market that found regulatory failings contributed to a lack of competition.

Read more…

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s